By David Tuller, DrPH Yet another interesting development has taken place at Cochrane, and this new development again suggests that things there might be moving in the right direction. On Friday, the organization withdrew a protocol for what is called an individual patient data (or IPD) review of exercise therapy for the illness it has …
Trial By Error: And Cochrane Makes Another Move… Read More »
By David Tuller, DrPH Earlier today, I sent the following e-mail to Dr Fiona Godlee, editorial director of BMJ. I cc’d Carol Monaghan MP, Darren Jones MP, and Nicky Morgan MP. I also cc’d Teresa Allen of the Health Research Authority. ********** Dear Dr. Godlee, As you know, I have spent some time criticizing a …
Trial By Error: How BMJ Enabled Bristol’s Ethics Exemptions Read More »
By David Tuller, DrPH In what can only be characterized as a welcome surprise, Cochrane has rejected the revision of a 2014 review of exercise treatments for chronic fatigue syndrome, stating that the work does not meet the organization’s quality standards. Cochrane revealed the decision late Friday in a statement appended to the review, which …
By David Tuller, DrPH The UK’s National Institute for Health and Care Excellence (NICE), which develops clinical guidelines for a range of medical conditions, is currently selecting a committee to develop a new guidance for the illness it refers to as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The new guidance will replace one written in 2007, …
By David Tuller, DrPH This morning I sent the following letter to Fiona Godlee, editor-in-chief of The BMJ and editorial director of BMJ. I cc-d Carol Monaghan MP, Darren Jones MP, and Nicky Morgan MP. **********
By David Tuller, DrPH Three years ago this month, Virology Blog published my 15,000-word investigation of the PACE trial, so this seems like a good time for a bit of reflection. I certainly didn’t expect this saga to drag on this long. I’ve kept at it mainly because of the UK academic and medical establishment’s …
